🔎 Trials Near Me

Home › Ulcerative Colitis › Rhode Island › Providence

Ulcerative Colitis clinical trials in Providence, RI

11 studies for Ulcerative Colitis are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 2
  • Site US-019, Providence
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07845487

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RecruitingPhase 2
  • Site 025, Providence
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 3
  • University Gastroenterology, Providence
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RecruitingPhase 3
  • University Gastroenterology, Providence
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RecruitingPhase 2
  • University Gastroenterology - Providence - West River Street, Providence
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RecruitingPhase 4
  • University Gastroenterology, Providence
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RecruitingPhase 4
  • University Gastroenterology, Providence
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT06581328

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 3
  • University Gastroenterology - GI Alliance - Site Number: 8400103, Providence
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting
  • Gastroenterology Associates, Providence
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2
  • Mirador Therapeutics Selected Site, Providence
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.